Megyesi C, Samols E, Marks V (1967) Glucose tolerance and diabetes in chronic liver disease. Lancet 2:1051–1056
Article
CAS
Google Scholar
Araújo TG, Oliveira AG, Saad MJ (2013) Insulin-resistance-associated compensatory mechanisms of pancreatic Beta cells: a current opinion. Front Endocrinol (Lausanne) 4:146
Article
Google Scholar
Goswami A, Bhargava N, Dadhich S, Kulamarva G (2014) Insulin resistance in euglycemic cirrhosis. Ann Gastroenterol 27:237–243
PubMed
PubMed Central
Google Scholar
Bonner-Weir S (2000) Perspective: postnatal pancreatic beta cell growth. Endocrinology 141:1926–1929
Article
CAS
Google Scholar
Flier SN, Kulkarni RN, Kahn CR (2001) Evidence for a circulating islet cell growth factor in insulin-resistant states. Proc Natl Acad Sci U S A 98:7475–7480
Article
CAS
Google Scholar
Douglas MW, George J (2009) Molecular mechanisms of insulin resistance in chronic hepatitis C. World J Gastroenterol 15:4356–4364
Article
CAS
Google Scholar
Leiherer A, Muendlein A, Geiger K, Saely C, Brandtner E, Ebner J, Larcher B, Mader A et al (2018) Betatrophin is associated with type 2 diabetes and markers of insulin resistance. Diabetes 67(Supp 1) 2445-PUB
Zhang R, Abou-Samra AB (2014) A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy. Cardiovasc Diabetol 13:133
Article
Google Scholar
Chen X, Lu P, He W, Zhang J, Liu L, Yang Y, Liu Z, Xie J et al (2015) Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. J Clin Endocrinol Metab 100:E96-100
PubMed
Google Scholar
Espes D, Martinell M, Carlsson PO (2014) Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol 2014:323407
Article
Google Scholar
Espes D, Lau J, Carlsson PO (2014) Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia 57:50–53
Article
CAS
Google Scholar
Fu Z, Berhane F, Fite A, Seyoum B, Abou-Samra AB, Zhang R (2014) Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep 4:5013
Article
CAS
Google Scholar
Gómez-Ambrosi J, Pascual E, Catalán V, Rodríguez A, Ramírez B, Silva C, Gil MJ, Salvador J et al (2014) Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab 99:E2004–E2009
Article
Google Scholar
Hu H, Sun W, Yu S, Hong X, Qian W, Tang B, Wang D, Yang L et al (2014) Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care 37:2718–2722
Article
CAS
Google Scholar
Arias-Loste MT, García-Unzueta MT, Llerena S, Iruzubieta P, Puente A, Cabezas J, Alonso C, Cuadrado A et al (2015) Plasma betatrophin levels in patients with liver cirrhosis. World J Gastroenterol 21:10662–10668
Article
CAS
Google Scholar
Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649
Article
CAS
Google Scholar
Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–871
Article
CAS
Google Scholar
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
Article
CAS
Google Scholar
Yi P, Park J-S, Melton DA (2013) Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell 153:747–758
Article
CAS
Google Scholar
Francque S, Verrijken A, Mertens I, Hubens G, Van Marck E, Pelckmans P, Michielsen P, Van Gaal L (2011) Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension. Int J Obes 35:270–278
Article
CAS
Google Scholar
Vincent MA, Montagnani M, Quon MJ (2003) Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr Diab Rep 3:279–288
Article
Google Scholar
Rockey DC (2006) Hepatic fibrosis, stellate cells, and portal hypertension. Clin Liver Dis 10:459–479
Article
Google Scholar
Iwakiri Y, Groszmann RJ (2007) Vascular endothelial dysfunction in cirrhosis. J Hepatol 46:927–934
Article
CAS
Google Scholar
Erice E, Llop E, Berzigotti A, Abraldes JG, Conget I, Seijo S, Reverter E, Albillos A et al (2012) Insulin resistance in patients with cirrhosis and portal hypertension. Am J Physiol Gastrointest Liver Physiol 302:G1458–G1465
Article
CAS
Google Scholar
Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M et al (2008) Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 134:416–423
Article
CAS
Google Scholar
Petta S, Cammà C, Di Marco V, Alessi N, Cabibi D, Caldarella R, Licata A, Massenti F et al (2008) Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol 103:1136–1144
Article
CAS
Google Scholar
Nkontchou G, Bastard JP, Ziol M, Aout M, Cosson E, Ganne-Carrie N, Grando-Lemaire V, Roulot D et al (2010) Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis. J Hepatol 53:827–833
Article
CAS
Google Scholar
Hung CH, Wang JH, Hu TH, Chen CH, Chang KC, Yen YH, Kuo YH, Tsai MC et al (2010) Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection. World J Gastroenterol 16:2265–2271
Article
CAS
Google Scholar
Kaser S, Föger B, Waldenberger P, Nachbaur K, Propst A, Jaschke W, Vogel W, Patsch JR (2000) Transjugular intrahepatic portosystemic shunt (TIPS) augments hyperinsulinemia in patients with cirrhosis. J Hepatol 33:902–906
Article
CAS
Google Scholar
Grancini V, Trombetta M, Lunati ME, Zimbalatti D, Boselli ML, Gatti S, Donato MF, Resi V et al (2015) Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease. J Hepatol 63:1484–1490
Article
CAS
Google Scholar
Greco AV, Mingrone G, Mari A, Capristo E, Manco M, Gasbarrini G (2002) Mechanisms of hyperinsulinaemia in Child’s disease grade B liver cirrhosis investigated in free living conditions. Gut 51:870–875
Article
CAS
Google Scholar
Raghow R (2013) Betatrophin: A liver-derived hormone for the pancreatic β-cell proliferation. World J Diabetes 4:234–237
Article
Google Scholar